We are live on ! Find out more
IMUX icon

Immunic
IMUX

44 hedge funds and large institutions have $125M invested in Immunic in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 6

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

22% more capital invested

Capital invested by funds: $102M → $125M (+$22.8M)

10% more funds holding

Funds holding: 40 → 44 (+4)

95% less call options, than puts

Call options by funds: $108K | Put options by funds: $2.25M

Holders
44
Holders Change
+4
Holders Change %
+10%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
20
Reduced
6
Closed
4
Calls
$108K
Puts
$2.25M
Net Calls
-$2.14M
Net Calls Change
-$2.14M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.89M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.35M
3
RIM
RS Investment Management
California
+$2.85M
4
DA
DSC Advisors
Illinois
+$1.03M
5
GGHC
Gilder Gagnon Howe & Co
New York
+$781K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$2.04M
2
Goldman Sachs
Goldman Sachs
New York
-$1.1M
3
DCM
Driehaus Capital Management
Illinois
-$723K
4
Citigroup
Citigroup
New York
-$597K
5
William Blair & Company
William Blair & Company
Illinois
-$443K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$51.8M +$7.35M +800 +18%
RIM
2
RS Investment Management
California
$27.3M +$2.85M +310 +13%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$10.8M +$9.89M +1,076 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$9.97M +$763K +83 +9%
BFA
5
BlackRock Fund Advisors
California
$4.06M +$101K +11 +3%
Deutsche Bank
6
Deutsche Bank
Germany
$2.48M -$73.5K -8 -3%
State Street
7
State Street
Massachusetts
$1.91M -$82.7K -9 -5%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$1.89M +$414K +45 +31%
Northern Trust
9
Northern Trust
Illinois
$1.74M +$211K +23 +15%
BIT
10
BlackRock Institutional Trust
California
$1.58M +$110K +12 +8%
SIM
11
Spark Investment Management
New York
$1.47M +$653K +71 +92%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.22M +$9.19K +1 +0.8%
DA
13
DSC Advisors
Illinois
$1.12M +$1.03M +112 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$1.08M +$147K +16 +17%
GGHC
15
Gilder Gagnon Howe & Co
New York
$849K +$781K +85 New
Bank of America
16
Bank of America
North Carolina
$672K -$147K -16 -19%
Swiss National Bank
17
Swiss National Bank
Switzerland
$494K +$119K +13 +36%
TCIM
18
TIAA CREF Investment Management
New York
$475K – – –
NFA
19
Nationwide Fund Advisors
Ohio
$470K – – –
TD Asset Management
20
TD Asset Management
Ontario, Canada
$420K +$386K +42 New
BIM
21
BlackRock Investment Management
Delaware
$402K +$9.19K +1 +3%
UOC
22
UBS O'Connor
Illinois
$375K +$119K +13 +52%
RJA
23
Raymond James & Associates
Florida
$366K +$340K +37 New
Morgan Stanley
24
Morgan Stanley
New York
$295K +$46K +5 +20%
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$263K – – –
1
2 3

IMUX Hedge Fund Activity: Q1 2015 in Review

44 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2015, worth a combined $125M — up 22% from $102M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new IMUX positions and 4 closed out — a net gain of 4 holders — while 20 added to existing stakes and 6 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $9.89M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $2.04M sold.

  • 44 institutional investors held Immunic (IMUX) as of Q1 2015, up from 40 in Q4 2014.
  • Funds reported $125M of Immunic stock for Q1 2015, up 22% quarter-over-quarter.
  • 8 funds opened new Immunic positions in Q1 2015 and 4 closed out, a net change of +4 holders.
  • The largest Immunic buyer in Q1 2015 was T. Rowe Price Associates, an estimated $9.89M added.
  • The largest Immunic seller in Q1 2015 was Sphera Funds Management, an estimated $2.04M sold.

Based on aggregated 13F filings for Q1 2015.